Boundless Bio GAAP EPS of -$0.62
Source: SeekingAlpha
2025-11-05 13:30:31 ET
More on Boundless Bio
- Seeking Alpha’s Quant Rating on Boundless Bio
- Historical earnings data for Boundless Bio
- Financial information for Boundless Bio
Read the full article on Seeking Alpha
For further details see:
Boundless Bio GAAP EPS of -$0.62
Audentes Therapeutics Inc.
NASDAQ: BOLD
BOLD Trading
1.32% G/L:
$1.155 Last:
9,908 Volume:
$1.16 Open:
BOLD Latest News
March 09, 2026 07:00:00 am
Boundless Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
February 05, 2026 07:00:00 am
Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
BOLD Stock Data
$25,819,564
17,662,247
6.34%
6
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
